WNT3A and neoplasm: Wnt3A-mediated pathway activation also reduced secondary tumor sphere size (Supplementary Fig. 5b–c), frequency (Supplementary Fig. 5d), and cell proliferation in non-Wnt MBs (Supplementary Fig. 5e).